This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Tivity Health Future Growth

Future criteria checks 2/6

Key information

12.5%

Earnings growth rate

10.6%

EPS growth rate

Healthcare earnings growth	17.3%
Revenue growth rate	12.1%
Future return on equity	n/a
Analyst coverage	Low
Last updated	n/a

Recent future growth updates

Recent updates

These 4 Measures Indicate That Tivity Health (NASDAQ:TVTY) Is Using Debt Reasonably Well

May 11

A Look At The Fair Value Of Tivity Health, Inc. (NASDAQ:TVTY)

Mar 04

We Think Tivity Health (NASDAQ:TVTY) Is Taking Some Risk With Its Debt

Feb 09

Investors Who Bought Tivity Health (NASDAQ:TVTY) Shares Five Years Ago Are Now Up 67%

Jan 12

Read This Before Selling Tivity Health, Inc. (NASDAQ:TVTY) Shares

Dec 15

Tivity Health EPS beats by $0.35, beats on revenue

Nov 05

Earnings and Revenue Growth Forecasts

NasdaqGS:TVTY - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2023	619	101	102	113	5
12/31/2022	552	84	110	133	4
3/31/2022	501	88	86	102	N/A
12/31/2021	481	107	72	87	N/A
9/30/2021	455	147	61	70	N/A
6/30/2021	424	60	66	75	N/A
3/31/2021	386	69	133	145	N/A
12/31/2020	438	57	154	169	N/A
9/30/2020	112	51	140	162	N/A
6/30/2020	320	48	137	164	N/A
3/31/2020	579	49	98	124	N/A
12/31/2019	633	45	58	82	N/A
9/30/2019	1,011	65	101	119	N/A
6/30/2019	859	76	103	117	N/A
3/31/2019	670	81	91	102	N/A
12/31/2018	606	98	100	109	N/A
9/30/2018	593	78	98	106	N/A
6/30/2018	579	73	99	107	N/A
3/31/2018	566	67	108	115	N/A
12/31/2017	557	61	99	105	N/A
9/30/2017	543	65	96	101	N/A
6/30/2017	530	50	50	56	N/A
3/31/2017	516	52	34	43	N/A
12/31/2016	501	56	33	47	N/A
9/30/2016	490	53	20	41	N/A
6/30/2016	478	61	35	63	N/A
3/31/2016	466	52	33	66	N/A
12/31/2015	452	44	N/A	64	N/A
9/30/2015	538	37	N/A	59	N/A
6/30/2015	610	26	N/A	62	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: TVTY's forecast earnings growth (12.5% per year) is above the savings rate (1.9%).

Earnings vs Market: TVTY's earnings (12.5% per year) are forecast to grow slower than the US market (12.8% per year).

High Growth Earnings: TVTY's earnings are forecast to grow, but not significantly.

Revenue vs Market: TVTY's revenue (12.1% per year) is forecast to grow faster than the US market (7.9% per year).

High Growth Revenue: TVTY's revenue (12.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if TVTY's Return on Equity is forecast to be high in 3 years time

This company has been acquired

Tivity Health Future Growth

Future criteria checks 2/6

Key information

Recent future growth updates

Price target increased to US$30.25

Tivity Health, Inc. Announces Financial Guidance for Fiscal Year Ending December 31, 2022

Price target increased to US$29.40

Consensus forecasts updated

Tivity Health, Inc. Provides Revenue Guidance for the Year 2022

Tivity Health, Inc. Updates Financial Guidance for the Year 2021

Recent updates

Tivity Health, Inc.(NasdaqGS:TVTY) dropped from NASDAQ Composite Index

Funds managed by Stone Point Capital LLC completed the acquisition of Tivity Health, Inc. (NasdaqGS:TVTY).

First quarter 2022 earnings: EPS and revenues miss analyst expectations

High number of new and inexperienced directors

Stone Point Capital LLC entered into a definitive agreement to acquire Tivity Health, Inc. (NasdaqGS:TVTY) for $1.6 billion.

Stone Point Capital LLC entered into a definitive agreement to acquire Tivity Health, Inc. (NasdaqGS:TVTY) for $1.6 billion.

We Think Tivity Health (NASDAQ:TVTY) Can Stay On Top Of Its Debt

Full year 2021 earnings: EPS misses analyst expectations

Price target increased to US$30.25

Tivity Health, Inc. Announces Financial Guidance for Fiscal Year Ending December 31, 2022

Tivity Health, Inc. to Report Q4, 2021 Results on Feb 24, 2022

Should You Be Adding Tivity Health (NASDAQ:TVTY) To Your Watchlist Today?

Does Tivity Health (NASDAQ:TVTY) Have A Healthy Balance Sheet?

Director recently sold US$997k worth of stock

Price target increased to US$29.40

Third quarter 2021 earnings released: EPS US$2.09 (vs US$0.87 loss in 3Q 2020)

Tivity Health, Inc. (NasdaqGS:TVTY) announces an Equity Buyback for $100 million worth of its shares.

A Look At The Fair Value Of Tivity Health, Inc. (NASDAQ:TVTY)

Reassessing Tivity Health After Shares' Huge Move Off Pandemic Low

Insider recently bought US$3.5m worth of stock

Consensus forecasts updated

Second quarter 2021 earnings released: EPS US$0.18 (vs US$0.58 in 2Q 2020)

Tivity Health, Inc. Provides Revenue Guidance for the Year 2022

Are Investors Undervaluing Tivity Health, Inc. (NASDAQ:TVTY) By 47%?

These 4 Measures Indicate That Tivity Health (NASDAQ:TVTY) Is Using Debt Reasonably Well

First quarter 2021 earnings released: EPS US$0.41 (vs US$4.08 loss in 1Q 2020)

Tivity Health, Inc. Updates Financial Guidance for the Year 2021

A Look At The Fair Value Of Tivity Health, Inc. (NASDAQ:TVTY)

Full year 2020 earnings released: EPS US$1.17 (vs US$6.17 loss in FY 2019)

Price target raised to US$24.20

Tivity Health, Inc. to Report Q4, 2020 Results on Feb 24, 2021

We Think Tivity Health (NASDAQ:TVTY) Is Taking Some Risk With Its Debt

New 90-day high: US$22.52

Investors Who Bought Tivity Health (NASDAQ:TVTY) Shares Five Years Ago Are Now Up 67%

Cohen Milstein Announces Pendency of Class Action Involving Purchasers of Tivity Health Common Stock

New 90-day high: US$19.85

Read This Before Selling Tivity Health, Inc. (NASDAQ:TVTY) Shares

New 90-day high: US$17.62

Analysts lower EPS estimates to -US$4.04

Tivity Health, Inc. Provides Update on Proposed Settlement of the Claims

Revenue beats expectations, earnings disappoint

Third quarter 2020 earnings released: US$0.87 loss per share

Price target raised to US$20.43

Tivity Health EPS beats by $0.35, beats on revenue

Tivity Health, Inc. Enters into Separation Agreement and General Release Agreement with Mary Flipse as Chief Legal and Administrative Officer

Kainos Capital LP entered into stock purchase agreement to acquire Nutrisystem, Inc. from Tivity Health, Inc. (NasdaqGS:TVTY) for approximately $580 million.

Tivity Health, Inc. Not to Provide Financial Guidance for the Year 2020

New 90-day high - US$17.10

Price target raised to US$18.94

First half earnings released

Tivity Health, Inc. to Report Q2, 2020 Results on Aug 05, 2020

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies